Skip to content
healthcare.dev

Deflazacort Oral Suspension

NDC 70377-188, Deflazacort Oral, suspension, from Biocon Pharma Inc..

Product NDC
70377-188
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA220709
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-188 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
70377-188-21703770188211 BOTTLE in 1 CARTON (70377-188-21) / 13 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e76f35a5-711c-c511-9fd8-b8c4c0b43b85

Use it

Look up 70377-188 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-188 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-188. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.